JP2024502466A5 - - Google Patents

Info

Publication number
JP2024502466A5
JP2024502466A5 JP2023541507A JP2023541507A JP2024502466A5 JP 2024502466 A5 JP2024502466 A5 JP 2024502466A5 JP 2023541507 A JP2023541507 A JP 2023541507A JP 2023541507 A JP2023541507 A JP 2023541507A JP 2024502466 A5 JP2024502466 A5 JP 2024502466A5
Authority
JP
Japan
Application number
JP2023541507A
Other languages
Japanese (ja)
Other versions
JP2024502466A (ja
JPWO2022150540A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011538 external-priority patent/WO2022150540A1/en
Publication of JP2024502466A publication Critical patent/JP2024502466A/ja
Publication of JP2024502466A5 publication Critical patent/JP2024502466A5/ja
Publication of JPWO2022150540A5 publication Critical patent/JPWO2022150540A5/ja
Pending legal-status Critical Current

Links

JP2023541507A 2021-01-08 2022-01-07 抗発作治療薬の急速な送達のための方法および組成物 Pending JP2024502466A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163135291P 2021-01-08 2021-01-08
US63/135,291 2021-01-08
US202163276761P 2021-11-08 2021-11-08
US202163276760P 2021-11-08 2021-11-08
US63/276,761 2021-11-08
US63/276,760 2021-11-08
US202163284033P 2021-11-30 2021-11-30
US63/284,033 2021-11-30
PCT/US2022/011538 WO2022150540A1 (en) 2021-01-08 2022-01-07 Methods and compositions for rapid delivery of anti-seizure therapeutics

Publications (3)

Publication Number Publication Date
JP2024502466A JP2024502466A (ja) 2024-01-19
JP2024502466A5 true JP2024502466A5 (https=) 2025-01-15
JPWO2022150540A5 JPWO2022150540A5 (https=) 2025-01-15

Family

ID=82323232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541507A Pending JP2024502466A (ja) 2021-01-08 2022-01-07 抗発作治療薬の急速な送達のための方法および組成物

Country Status (6)

Country Link
US (2) US20220218598A1 (https=)
EP (1) EP4274618A4 (https=)
JP (1) JP2024502466A (https=)
KR (1) KR20230144019A (https=)
AU (1) AU2022206421A1 (https=)
WO (1) WO2022150540A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117580579A (zh) * 2021-06-10 2024-02-20 纽瑞莱斯有限公司 用于治疗儿科患者的癫痫发作病症的方法和组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
CA2756690C (en) * 2008-03-28 2016-08-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
EP2694076A4 (en) * 2011-04-01 2014-08-27 Cpex Pharmaceuticals Inc Nasal formulations of benzodiazepine
EP4085899A1 (en) * 2011-06-14 2022-11-09 Neurelis, Inc. Administration of benzodiazepine

Similar Documents

Publication Publication Date Title
JP2024502466A5 (https=)
CL2025004171A1 (es) Proceso para la fabricación de elementos protectores para celdas de electrolisis de agua alcalina
CL2025004035A1 (es) Supervisión del volumen de una obra subterránea.
CL2025002898A1 (es) Detección de proximidad.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13176U (https=)
BY13144U (https=)
CN307044839S (https=)
BY13160U (https=)
BY13159U (https=)
BY13158U (https=)
BY13157U (https=)
BY13156U (https=)
BY13155U (https=)
CN307045763S (https=)